Our study shows that supernatants of both WFDC1- and IL-17D-overexpressed, SORBS2-depleted ovarian cancer cells significantly reduced the amount of HLA-DRlo/neg CD14+ cells in vitro. This evidence concerns the gene IL17D and ovarian carcinoma.